Imidazo-diazepines and their use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2602393T, 2602393B, 2602393D, A61K 3155, C07D48704, C07D51314

Patent

active

043528171

ABSTRACT:
There is provided imidazodiazepines of the formula ##STR1## wherein A together with the two carbon atoms denoted as .alpha. and .beta. is the group ##STR2## X is an oxygen or sulphur atom and R.sup.1 is hydrogen or lower alkyl, and either R.sup.2 is hydrogen, trifluoromethyl, halogen, cyano or nitro and R.sup.3 is hydrogen or R.sup.2 is hydrogen and R.sup.3 is trifluoromethyl, halogen, cyano, nitro or lower alkyl,
and their pharmaceutically acceptable acid addition salts. The compounds are useful in the antagonization of the central-depressant, muscle relaxant, ataxic, blood pressure-lowering and respiratory-depressant properties of 1,4-benzodiazepines which have tranquillizing activity, for example as antidotes in the case of intoxications with 1,4-benzodiazepines which have tranquillizing activity.
Also presented are methods to produce the above imidazodiazepines.

REFERENCES:
patent: 4316832 (1982-02-01), Gerecke et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazo-diazepines and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazo-diazepines and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo-diazepines and their use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-423239

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.